247 related articles for article (PubMed ID: 23630294)
21. The HDAC inhibitor SAHA improves depressive-like behavior of CRTC1-deficient mice: Possible relevance for treatment-resistant depression.
Meylan EM; Halfon O; Magistretti PJ; Cardinaux JR
Neuropharmacology; 2016 Aug; 107():111-121. PubMed ID: 26970016
[TBL] [Abstract][Full Text] [Related]
22. Distribution of RGS4 mRNA in mouse brain shown by in situ hybridization.
Nomoto S; Adachi K; Yang LX; Hirata Y; Muraguchi S; Kiuchi K
Biochem Biophys Res Commun; 1997 Dec; 241(2):281-7. PubMed ID: 9425263
[TBL] [Abstract][Full Text] [Related]
23. Genetic deletion of regulator of G-protein signaling 4 (RGS4) rescues a subset of fragile X related phenotypes in the FMR1 knockout mouse.
Pacey LK; Doss L; Cifelli C; van der Kooy D; Heximer SP; Hampson DR
Mol Cell Neurosci; 2011 Mar; 46(3):563-72. PubMed ID: 21215802
[TBL] [Abstract][Full Text] [Related]
24. Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests.
Andreasen JT; Gynther M; Rygaard A; Bøgelund T; Nielsen SD; Clausen RP; Mogensen J; Pickering DS
Neurosci Lett; 2013 Jun; 546():6-10. PubMed ID: 23643996
[TBL] [Abstract][Full Text] [Related]
25. Diverse antidepressants increase CDP-diacylglycerol production and phosphatidylinositide resynthesis in depression-relevant regions of the rat brain.
Tyeryar KR; Vongtau HO; Undieh AS
BMC Neurosci; 2008 Jan; 9():12. PubMed ID: 18218113
[TBL] [Abstract][Full Text] [Related]
26. Effect of antidepressant drugs on the vmPFC-limbic circuitry.
Chang CH; Chen MC; Lu J
Neuropharmacology; 2015 May; 92():116-24. PubMed ID: 25637091
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of RGS proteins in the prefrontal cortex of short- and long-term human opiate abusers.
Rivero G; Gabilondo AM; García-Fuster MJ; La Harpe R; García-Sevilla JA; Meana JJ
Neuropharmacology; 2012 Feb; 62(2):1044-51. PubMed ID: 22056472
[TBL] [Abstract][Full Text] [Related]
28. Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay.
Roman DL; Talbot JN; Roof RA; Sunahara RK; Traynor JR; Neubig RR
Mol Pharmacol; 2007 Jan; 71(1):169-75. PubMed ID: 17012620
[TBL] [Abstract][Full Text] [Related]
29. The regulator of G protein signaling RGS4 selectively enhances alpha 2A-adreoreceptor stimulation of the GTPase activity of Go1alpha and Gi2alpha.
Cavalli A; Druey KM; Milligan G
J Biol Chem; 2000 Aug; 275(31):23693-9. PubMed ID: 10807934
[TBL] [Abstract][Full Text] [Related]
30. Selectivity and anti-Parkinson's potential of thiadiazolidinone RGS4 inhibitors.
Blazer LL; Storaska AJ; Jutkiewicz EM; Turner EM; Calcagno M; Wade SM; Wang Q; Huang XP; Traynor JR; Husbands SM; Morari M; Neubig RR
ACS Chem Neurosci; 2015 Jun; 6(6):911-9. PubMed ID: 25844489
[TBL] [Abstract][Full Text] [Related]
31. Regulators of G-protein signaling 2 and 4 differentially regulate cocaine-induced rewarding effects.
Rorabaugh BR; Rose MJ; Stoops TS; Stevens AA; Seeley SL; D'Souza MS
Physiol Behav; 2018 Oct; 195():9-19. PubMed ID: 30036561
[TBL] [Abstract][Full Text] [Related]
32. Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia.
Benbouzid M; Gavériaux-Ruff C; Yalcin I; Waltisperger E; Tessier LH; Muller A; Kieffer BL; Freund-Mercier MJ; Barrot M
Biol Psychiatry; 2008 Mar; 63(6):633-6. PubMed ID: 17693391
[TBL] [Abstract][Full Text] [Related]
33. Full length cloning and expression analysis of splice variants of regulator of G-protein signaling RGS4 in human and murine brain.
Ding L; Mychaleckyj JC; Hegde AN
Gene; 2007 Oct; 401(1-2):46-60. PubMed ID: 17707117
[TBL] [Abstract][Full Text] [Related]
34. Intrathecal RGS4 inhibitor, CCG50014, reduces nociceptive responses and enhances opioid-mediated analgesic effects in the mouse formalin test.
Yoon SY; Woo J; Park JO; Choi EJ; Shin HS; Roh DH; Kim KS
Anesth Analg; 2015 Mar; 120(3):671-677. PubMed ID: 25695583
[TBL] [Abstract][Full Text] [Related]
35. Splicing factor transformer-2β (Tra2β) regulates the expression of regulator of G protein signaling 4 (RGS4) gene and is induced by morphine.
Li SJ; Li Y; Cui SC; Qi Y; Zhao JJ; Liu XY; Xu P; Chen XH
PLoS One; 2013; 8(8):e72220. PubMed ID: 23977258
[TBL] [Abstract][Full Text] [Related]
36. Regulators of G-protein signaling, RGS2 and RGS4, inhibit protease-activated receptor 4-mediated signaling by forming a complex with the receptor and Gα in live cells.
Kim Y; Ghil S
Cell Commun Signal; 2020 Jun; 18(1):86. PubMed ID: 32517689
[TBL] [Abstract][Full Text] [Related]
37. Depression-resistant Phenotype in Mice Overexpressing Regulator of G Protein Signaling 8 (RGS8).
Kobayashi Y; Takemoto R; Yamato S; Okada T; Iijima M; Uematsu Y; Chaki S; Saito Y
Neuroscience; 2018 Jul; 383():160-169. PubMed ID: 29758252
[TBL] [Abstract][Full Text] [Related]
38. Regulators of G Protein Signaling in Analgesia and Addiction.
Sakloth F; Polizu C; Bertherat F; Zachariou V
Mol Pharmacol; 2020 Dec; 98(6):739-750. PubMed ID: 32474445
[TBL] [Abstract][Full Text] [Related]
39. Tianeptine promotes lasting antiallodynic effects in a mouse model of neuropathic pain.
Serafini RA; Estill M; Pekarskaya EA; Sakloth F; Shen L; Javitch JA; Zachariou V
Neuropsychopharmacology; 2023 Oct; 48(11):1680-1689. PubMed ID: 37474762
[TBL] [Abstract][Full Text] [Related]
40. Mu opioid receptor activation enhances regulator of G protein signaling 4 association with the mu opioid receptor/G protein complex in a GTP-dependent manner.
Santhappan R; Crowder AT; Gouty S; Cox BM; Côté TE
J Neurochem; 2015 Oct; 135(1):76-87. PubMed ID: 26119705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
